Over the last six years, Target ALS developed a unique Innovation Ecosystem that is driving measurable scientific progress. Twelve new therapeutic options have emerged, and we are poised to radically improve our ability to translate these findings into the next generation of clinical trials for ALS patients. With your help, we can achieve breakthrough results for patients. Sign up to receive the latest research news and learn how you can help accelerate discovery.